EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

CD4 + T Cell NRF2 Signaling Improves Liver Transplantation Outcomes by Modulating T Cell Activation and Differentiation

Hidenobu Kojima, Kentaro Kadono, Hirofumi Hirao, Kenneth J Dery, Jerzy W Kupiec-Weglinski iD

Antioxidants & Redox Signaling · 2023-03 · 38 (7-9) · 670-683

DOI: 10.1089/ars.2022.0094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 16.03.2023. Verfasst von Hidenobu Kojima und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCL…. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Diseases, Reperfusion Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Innate and adaptive immune responses regulate hepatic ischemia–reperfusion injury (IRI) in orthotopic liver transplantation (OLT). While the mechanism of how nuclear factor erythroid 2-related factor 2 (NRF2) plays a role in liver IRI has been studied, the contribution of T cell-specific NRF2 in OLT remains unknown. In the current translational study, we investigated whether and how CD4 + T cell-specific NRF2 signaling affects liver transplant outcomes in mice and humans.

Results

In the experimental arm, cold-stored (4°C/18 h) wild-type (WT) mouse livers transplanted to NRF2-deficient (NRF2-knockout [NRF2-KO]) recipients experienced greater hepatocellular damage than those in Nrf2-proficient (WT) counterparts, evidenced by Suzuki's histological scores, frequency of TdT-mediated dUTP nick end labeling (TUNEL) + cells, and elevated serum aspartate aminotransferase/alanine aminotransferase (AST/ALT) levels. In vitro studies showed that NRF2 signaling suppressed CD4 + T cell differentiation to a proinflammatory phenotype (Th1, Th17) while promoting the regulatory (Foxp3 + ) T cell lineage. Furthermore, OLT injury deteriorated in immune-compromised RAG2-KO test recipients repopulated with CD4 + T cells from NRF2-KO compared with WT donor mice. In the clinical arm of 45 human liver transplant patients, the perioperative increase of NRF2 expression in donor livers negatively regulated innate and adaptive immune activation, resulting in reduced hepatocellular injury in NRF2-proficient OLT. Innovation and Conclusion: CD4 + T cell population expressing NRF2 attenuated ischemia and reperfusion (IR)-triggered hepatocellular damage in a clinically relevant mouse model of extended donor liver cold storage, followed by OLT, whereas the perioperative increase of NRF2 expression reduced hepatic injury in human liver transplant recipients. Thus, CD4 + T cell NRF2 may be a novel cytoprotective sentinel against IR stress in OLT recipients. Antioxid. Redox Signal. 38, 670–683.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLiver DiseasesReperfusion InjuryHumansMiceAnimalsNF-E2-Related Factor 2T-LymphocytesLiving DonorsLiverCD4-Positive T-LymphocytesCell DifferentiationMice, Inbred C57BL

Stichwörter der Autor:innen

NRF2T cell differentiationliver ischemia–reperfusion injuryliver transplantationtranslational research

Substanzen

NF-E2-Related Factor 2

Autor:innen und Institutionen

  • The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

ORCID-Profile: Jerzy W Kupiec-Weglinski

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Kojima, H., Kadono, K., Hirao, H., Dery, K. J., & Kupiec-Weglinski, J. W. (2023). CD4 + T Cell NRF2 Signaling Improves Liver Transplantation Outcomes by Modulating T Cell Activation and Differentiation. Antioxidants & Redox Signaling, 38(7-9), 670-683. https://doi.org/10.1089/ars.2022.0094

Vancouver

Kojima H, Kadono K, Hirao H, Dery KJ, Kupiec-Weglinski JW. CD4 + T Cell NRF2 Signaling Improves Liver Transplantation Outcomes by Modulating T Cell Activation and Differentiation. Antioxidants & Redox Signaling. 2023;38(7-9):670-683. doi:10.1089/ars.2022.0094

BibTeX
@article{Kojima2023,
  author = {Kojima, Hidenobu and Kadono, Kentaro and Hirao, Hirofumi and Dery, Kenneth J and Kupiec-Weglinski, Jerzy W},
  title = {CD4 + T Cell NRF2 Signaling Improves Liver Transplantation Outcomes by Modulating T Cell Activation and Differentiation},
  journal = {Antioxidants & Redox Signaling},
  year = {2023},
  volume = {38},
  number = {7-9},
  pages = {670--683},
  doi = {10.1089/ars.2022.0094}
}
Kostenlos starten →